Boston Scientific Invests in Intelect

Xconomy Boston — 

Boston Scientific (NYSE:BSX), a Natick, MA-based medical devices firm, has led an equity round expected to total $11 milion to $13.5 million in Intelect Medical, a developer of an implantable neuromodulation system headquartered in Cleveland, Intelect reports in a statement. Intelect says, as part of the deal, it has granted Boston Scientific co-exclusive rights to its software under development to provide graphical information on electrical changes made by electrodes in the brain.